C12Y 114/21
Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen
Official title: with NADH or NADPH as one donor, and the other dehydrogenated (1.14.21)
C12Y114/21 (Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen) appears on 6 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 7
- Assignees
- 4
- Inventors
- 8
- Latest grant
- 31 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Subgroups
Granted patents
- C12Y 114/21004Salutaridine synthase3
- C12Y 114/21001-stylopine synthase2
- C12Y 114/21002-cheilanthifoline synthase2
- C12Y 114/21003Berbamunine synthase0
- C12Y 114/21005-canadine synthase0
- C12Y 114/21006Lathosterol oxidase , i.e. c-5 sterol desaturase0
- C12Y 114/21007Biflaviolin synthase0
- C12Y 114/21008Pseudobaptigenin synthase0
Recent patents
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids31 Dec 2024US 12,180,525 B2Antheia, Inc.
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids26 Jul 2022US 11,396,668 B2Antheia, Inc.
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids11 Aug 2020US 10,738,335 B2Antheia, Inc.
- Compositions and methods for producing podophyllotoxin derivatives12 Nov 2019US 10,472,688 B2The Board of Trustees of the Leland Stanford Junior University
- Biosynthesis of opiate alkaloids9 Jan 2018US 9,862,979 B2Sun Pharmaceutical Industries (Australia) Pty Ltd
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids1 May 2025US 2025/0137021 A1Antheia, Inc.
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids6 Apr 2023US 2023/0104286 A1Antheia, Inc.
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids25 Mar 2021US 2021/0087596 A1Antheia, Inc.
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids16 May 2019US 2019/0144900 A1Antheia, Inc.
- Compositions and methods for producing podophyllotoxin derivatives30 Mar 2017US 2017/0088872 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Biosynthesis of opiate alkaloids20US 9,447,444 B2Sun Pharmaceutical Industries (Australia) Pty Ltd · 2016
- Biosynthesis of opiate alkaloids16US 9,862,979 B2Sun Pharmaceutical Industries (Australia) Pty Ltd · 2018
- Compositions and methods for producing podophyllotoxin derivatives2US 10,472,688 B2The Board of Trustees of the Leland Stanford Junior University · 2019
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids2US 10,738,335 B2Antheia, Inc. · 2020
- Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids1US 11,396,668 B2Antheia, Inc. · 2022